Share

Berenberg is bullish on BioNTech stock, not just for its Covid vaccine

More data is needed to see if new coronavirus variant will bring additional risks to the efficacy of its vaccines, but BioNTech stocks should continue to move higher this year on strong commercial performance, says Zhiqiang Shu of Berenberg Capital Markets.
02:45
Tue, Jan 12 20212:04 AM EST

watch now
VIDEO07:08
CNBC ProLogitech CEO talks Q3 results, says company is at the center of the future of work
watch now
VIDEO11:31
CNBC ProJim Cramer says most 'Go To' stocks are still worth buying, despite gains
watch now
VIDEO05:01
CNBC ProInteractive Brokers Chairman says new accounts are active
watch now
VIDEO08:16
CNBC ProLemonade CEO discusses how its business model builds trust with consumers
watch now
VIDEO10:52
CNBC ProJeff Ubben on investing in AppHarvest